Table 2.
Clinical data after 12 ± 2 months of optimized therapy
Overall cohort | Group A FEV1 ≥ 80% |
Group B FEV1 < 80 ≥ 60% |
Group C FEV1 < 60% |
|
---|---|---|---|---|
n | 817 | 508 | 202 | 107 |
FEV1% | 93.79 (±0.70) | 103.92 (±0.60) | 83.92 (±1.00) | 64.34 (±1.73) |
Relapses, n,a | 0.45 (±0.03) | 0.31 (±0.03) | 0.62 (±0.08) | 0.79 (±0.12) |
Mean (±SE, standard error)
FEV1%: forced expiratory volume in 1 s, predicted values
aRelapses with and without hospitalization